A positive PCR can mean you were infected three weeks ago. A negative antigen test on day one of symptoms means very little. A positive antibody test tells you about the past, not the present. These three test types answer fundamentally different questions, and confusing them costs lives in outbreaks where time matters.
This post sits inside the pandemic preparedness 101 hub and complements the outbreak lab testing guide. It is the explainer you want bookmarked before the next surge, not after.
Key Takeaways
- PCR detects pathogen genetic material; it is the most sensitive but slowest method.
- Antigen tests detect viral proteins; they are fast and cheap but less sensitive than PCR.
- Serology detects host antibodies; it answers "have you been exposed?" not "are you infected right now?"
- A positive PCR can persist for weeks after infectiousness ends.
- A negative rapid antigen test in early symptoms or asymptomatic exposure does not rule out infection.
- Test choice depends on the clinical question: diagnosis, screening, surveillance, or seroprevalence.
What does a PCR test detect?
PCR (polymerase chain reaction) amplifies specific genetic sequences from the pathogen, typically RNA for viruses like SARS-CoV-2, influenza, RSV, or HIV. The test cycles through temperature changes to double the target sequence about 30 to 45 times. Detection of the amplified product confirms the pathogen is present. Sensitivity reaches one virion per microliter or lower.
PCR is the gold standard for diagnosis. It detects active infection while pathogen is replicating and continues to detect fragments for days or weeks after replication stops. The cycle threshold (Ct) value gives a rough proxy for viral load: lower Ct means more virus.
Turnaround time varies. Point-of-care PCR (Cepheid GeneXpert, Abbott ID Now) returns results in 15 to 45 minutes. Standard laboratory PCR runs 4 to 24 hours. The trade-off is throughput; lab PCR processes thousands of samples per day.
What does an antigen test detect?
Antigen tests detect specific viral proteins, usually nucleocapsid or spike for coronaviruses, using antibodies coated on a test strip. Sample contacts the antibody, captured antigen binds a labeled second antibody, and a visible line appears within 10 to 15 minutes. The familiar at-home COVID test is a lateral flow antigen assay.
Sensitivity is lower than PCR. Antigen tests typically detect infection when viral load is high enough to be infectious (around 100,000 copies per mL or higher). This makes them strong at identifying people who are likely contagious right now, but weak at detecting early infection before viral load peaks.
The strength of antigen tests is speed and accessibility. A 15-minute home test costing $5 enables behavior changes that a 4-hour lab PCR cannot. Their weakness is window: testing on day 1 of symptoms or after asymptomatic exposure misses a meaningful fraction of true cases.
| Feature | PCR | Antigen | Serology |
|---|---|---|---|
| Detects | Genetic material | Viral protein | Host antibodies |
| Sensitivity | Highest | Moderate | High for past infection |
| Specificity | Very high | High | Moderate (cross-reactivity) |
| Turnaround | 15 min to 24 hr | 15 to 30 min | 30 min to several days |
| Use case | Diagnosis, surveillance | Screening, infectiousness | Seroprevalence, immunity |
| Cost per test | $25 to $150 | $2 to $25 | $10 to $100 |
What does serology test for?
Serology measures antibodies in blood: IgM (early, weeks 1 to 4), IgG (later and durable), and sometimes IgA. The test answers whether the immune system has been exposed to a specific pathogen. It does not say whether the person is currently infected, only that they have been at some point or have been vaccinated.
IgM rises about 7 to 14 days after infection, IgG about 14 to 28 days. Both can persist for months to years depending on the pathogen and the individual. Vaccination produces antibodies that look similar to natural infection on many assays.
Serology is the right tool for seroprevalence studies (what fraction of a population has been exposed), suspected past infections that were never diagnosed, and some autoimmune workups. It is the wrong tool for confirming whether someone is currently sick.
When should you use which test?
Match the test to the clinical question.
- Currently symptomatic, want to know if it is X disease? PCR is the first choice. Antigen is acceptable if symptoms are well-developed (typically day 2 to 5).
- Asymptomatic but exposed, need to clear for work or travel? PCR captures earlier infection. Antigen catches infection at peak viral load.
- Returning to a high-risk setting after illness? Antigen is the better infectiousness check. PCR can stay positive long past contagion.
- Want to know if you have been previously infected? Serology is the only option.
- Population surveillance? PCR for circulating strain identification (often with sequencing); antigen for community screening; serology for historical exposure.
- Wastewater surveillance? PCR detects pathogen genetic material in sewage at population scale without individual testing.
What about home rapid tests?
Home rapid tests are antigen lateral flow assays. They work best when used serially (two tests 48 hours apart) and when symptoms are present. A single negative test in early infection has poor predictive value. Two negative tests over 48 hours during symptoms is much stronger evidence against current infectiousness.
Storage matters. Lateral flow strips degrade at high temperatures and after the printed expiration date. A test that sat in a hot car for a summer may give false negatives. Check expiration before relying on results.
CDC and FDA have extended expiration dates for several COVID-19 home test brands as stability data accumulates. The FDA expiration extension list is searchable at fda.gov.
How does this fit into surveillance?
The three test types each contribute to outbreak detection. PCR and sequencing identify what is circulating and how it is changing (read more about genomic surveillance). Antigen testing enables high-volume community screening during surges. Serology surveys reveal cumulative exposure and identify undercounted populations.
Layering them gives a fuller picture. CDC and ECDC weekly respiratory dashboards integrate PCR percent positive (active transmission), antigen positivity from sentinel networks (community spread), and periodic serosurveys (population immunity).
The goal of outbreak surveillance is signal, not certainty. The contact tracing post covers how positive results then connect to person-level response.
FAQ
Why can PCR stay positive after you are no longer contagious?
PCR detects genetic material whether or not the virus is intact and replicating. After infection clears, fragments of viral RNA persist in respiratory tissue for days or weeks. The Ct value tends to rise (less material) over time, but a positive PCR alone does not indicate current infectiousness for many respiratory viruses.
Are antigen tests reliable?
For their intended use, yes. Antigen tests catch most infections when viral load is high enough to spread. They miss some early or low-viral-load cases. Performance varies by manufacturer and depends on correct sample collection. Repeat testing over 48 hours improves reliability substantially.
Can a single antibody test confirm immunity?
No, with rare exceptions. Antibody presence does not equal protection. Neutralization assays give a closer answer but are not routine. Vaccine response and natural infection produce different antibody profiles for many pathogens. Public health agencies generally do not recommend serology to determine personal protection status.
What is a Ct value and what does it mean?
The cycle threshold (Ct) is the PCR amplification cycle at which the pathogen signal becomes detectable. A low Ct (around 15 to 25) suggests high viral load. A high Ct (35+) suggests low load near the detection limit. Ct is a rough proxy and varies by assay, sample quality, and stage of infection.
Do PCR tests detect new variants?
Most PCR assays target conserved regions and detect variants reliably. A few have lost sensitivity to specific variants when mutations affect the target region; manufacturers update primers as needed. Sequencing on PCR-positive samples is what actually identifies the variant.